E
Emily Kim
Researcher at Harvard University
Publications - 25
Citations - 3527
Emily Kim is an academic researcher from Harvard University. The author has contributed to research in topics: GTPase-activating protein & RGS Proteins. The author has an hindex of 19, co-authored 25 publications receiving 3395 citations. Previous affiliations of Emily Kim include University of Freiburg & Beth Israel Deaconess Medical Center.
Papers
More filters
Journal ArticleDOI
RIP : a novel protein containing a death domain that interacts with Fas/APO-1 (CD95) in yeast and causes cell death
TL;DR: Transient overexpression of RIP causes transfected cells to undergo the morphological changes characteristic of apoptosis, and these properties indicate that RIP is a novel form of apoptotic-inducing protein.
Journal ArticleDOI
Homo- and heterodimeric interactions between the gene products of PKD1 and PKD2.
TL;DR: In this paper, the C-terminal cytoplasmic tails of PKD1 and PKD2 were found to form homodimers through a coiled-coil domain distinct from the region required for interaction with PKD 1.
Journal ArticleDOI
Specific association of the gene product of PKD2 with the TRPC1 channel
TL;DR: In this paper, sequence homology between PKD2 and various members of the mammalian transient receptor potential channel (TRPC) proteins, thought to be activated by G protein-coupled receptor activation and/or depletion of internal Ca2+ stores, was described.
Journal ArticleDOI
The Polycystic Kidney Disease 1 Gene Product Modulates Wnt Signaling
Emily Kim,Thierry Arnould,Lorenz Sellin,Thomas Benzing,Melinda J. Fan,Wolfram R. Grüning,Sergei Y. Sokol,Iain A. Drummond,Gerd Walz +8 more
TL;DR: It is reported here that expression of the C-terminal cytoplasmic domain of polycystin stabilizes soluble endogenous β-catenin and stimulates TCF-dependent gene transcription in human embryonic kidney cells, and suggest that poly Cystin has the capacity to modulate Wnt signaling during renal development.
Journal ArticleDOI
Trafficking of TRPP2 by PACS proteins represents a novel mechanism of ion channel regulation.
Michael Köttgen,Thomas Benzing,Thomas Simmen,Robert Tauber,Björn Buchholz,Sylvain F. Feliciangeli,Tobias B. Huber,Bernhard Schermer,Albrecht Kramer-Zucker,Katja Höpker,Katia Carmine Simmen,Christoph Carl Tschucke,Richard Sandford,Emily Kim,Gary Thomas,Gerd Walz +15 more
TL;DR: The paradigm that polycystin‐2 is sorted to and active at both ER and plasma membrane reconciles the previously incongruent views of its localization and function is reconciled.